Literature DB >> 8143773

Cyclin B1 expression in HeLa S3 cells studied by flow cytometry.

S W Sherwood1, D F Rush, A L Kung, R T Schimke.   

Abstract

Using a procedure to stain cells simultaneously for cyclin B1 protein and DNA, we have examined cyclin B1 expression by flow cytometry in human cells under a variety of perturbing and nonperturbing conditions. The method described is useful for measuring relative differences in cyclin B level (immunochemically detectable epitope) as a function of cell cycle position on an individual cell basis and thus to examine cell cycle-related changes in cyclin B expression without prior cell synchronization. We show that in HeLaS3 cells, cyclin B1 accumulates in cells only after they become 4C and have resided in G2 for a short period of time. During colcemid-induced mitotic arrest cyclin B1 continues to accumulate in HeLa S3 cells, and under specific conditions of aphidicolin-induced unbalanced cell growth induced, cyclin B accumulates to supranormal levels prior to mitosis. Flow cytometric analysis of cyclin B expression and DNA content permits detailed examination of the effects of cell cycle perturbations on cyclin B expression under a variety of conditions.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8143773     DOI: 10.1006/excr.1994.1087

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  10 in total

1.  Measuring cell cycle progression kinetics with metabolic labeling and flow cytometry.

Authors:  Helen Fleisig; Judy Wong
Journal:  J Vis Exp       Date:  2012-05-22       Impact factor: 1.355

2.  Mismatch repair proteins are activators of toxic responses to chromium-DNA damage.

Authors:  Elizabeth Peterson-Roth; Mindy Reynolds; George Quievryn; Anatoly Zhitkovich
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

3.  Very late DNA replication in the human cell cycle.

Authors:  R J Widrow; R S Hansen; H Kawame; S M Gartler; C D Laird
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-15       Impact factor: 11.205

4.  Quantitative reconstitution of mitotic CDK1 activation in somatic cell extracts.

Authors:  Richard W Deibler; Marc W Kirschner
Journal:  Mol Cell       Date:  2010-03-26       Impact factor: 17.970

5.  Quantitative kinase and phosphatase profiling reveal that CDK1 phosphorylates PP2Ac to promote mitotic entry.

Authors:  Isha Nasa; Lauren E Cressey; Thomas Kruse; Emil P T Hertz; Jiang Gui; Lee M Graves; Jakob Nilsson; Arminja N Kettenbach
Journal:  Sci Signal       Date:  2020-09-08       Impact factor: 8.192

6.  The microarchitecture of DNA replication domains.

Authors:  Anatoly A Philimonenko; Zdenek Hodný; Dean A Jackson; Pavel Hozák
Journal:  Histochem Cell Biol       Date:  2005-10-25       Impact factor: 4.304

7.  Merging high-quality biochemical fractionation with a refined flow cytometry approach to monitor nucleocytoplasmic protein expression throughout the unperturbed mammalian cell cycle.

Authors:  Margit Rosner; Katharina Schipany; Markus Hengstschläger
Journal:  Nat Protoc       Date:  2013-02-28       Impact factor: 13.491

8.  Elucidation of proliferative capability of mononuclear tetraploid cells, emerging spontaneously from diploid cells, using image cytometry and fluorescence in situ hybridization.

Authors:  Hideaki Ito; Atsunori Oga; Tomoko Furuya; Kenzo Ikemoto; Genta Amakawa; Yasuyo Chochi; Shigeto Kawauchi; Kohsuke Sasaki
Journal:  Cell Prolif       Date:  2013-06       Impact factor: 6.831

9.  DNA replication is highly resilient and persistent under the challenge of mild replication stress.

Authors:  Camelia Mocanu; Eleftheria Karanika; María Fernández-Casañas; Alex Herbert; Tomisin Olukoga; Mete Emir Özgürses; Kok-Lung Chan
Journal:  Cell Rep       Date:  2022-04-19       Impact factor: 9.995

10.  CDK-1 Inhibition in G2 Stabilizes Kinetochore-Microtubules in the following Mitosis.

Authors:  A Sophia Gayek; Ryoma Ohi
Journal:  PLoS One       Date:  2016-06-09       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.